Abatacept for the treatment of rheumatoid arthritis

Volume: 15, Issue: 4, Pages: 319 - 326
Published: Feb 18, 2019
Abstract
Introduction: Rheumatoid arthritis (RA) is a complex disease in which different mechanisms are involved. Studies suggest a key role for aberrant pathways of T-cell activation in the initiation and perpetuation of disease. Abatacept is a fusion protein composed of the Fc region of the immunoglobulin G1 (IgG1) fused to the extracellular domain of cytotoxic T lymphocyte-associated antigen (CTLA4). It has the ability to modulate T-cell activation by...
Paper Details
Title
Abatacept for the treatment of rheumatoid arthritis
Published Date
Feb 18, 2019
Volume
15
Issue
4
Pages
319 - 326
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.